Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Identification of 31 loci for mammographic density phenotypes and their associations with breast cancer risk. Nature communications Sieh, W., Rothstein, J. H., Klein, R. J., Alexeeff, S. E., Sakoda, L. C., Jorgenson, E., McBride, R. B., Graff, R. E., McGuire, V., Achacoso, N., Acton, L., Liang, R. Y., Lipson, J. A., Rubin, D. L., Yaffe, M. J., Easton, D. F., Schaefer, C., Risch, N., Whittemore, A. S., Habel, L. A. 2020; 11 (1): 5116

Abstract

Mammographic density (MD) phenotypes are strongly associated with breast cancer risk and highly heritable. In this GWAS meta-analysis of 24,192 women, we identify 31 MD loci at P<5*10-8, tripling the number known to 46. Seventeen identified MD loci also are associated with breast cancer risk in an independent meta-analysis (P<0.05). Mendelian randomization analyses show that genetic estimates of dense area (DA), nondense area (NDA), and percent density (PD) are all significantly associated with breast cancer risk (P<0.05). Pathway analyses reveal distinct biological processes involving DA, NDA and PD loci. These findings provide additional insights into the genetic basis of MD phenotypes and their associations with breast cancer risk.

View details for DOI 10.1038/s41467-020-18883-x

View details for PubMedID 33037222